140 related articles for article (PubMed ID: 35116999)
1. MicroRNA-497-5p negatively regulates the proliferation and cisplatin resistance of non-small cell lung cancer cells by targeting YAP1 and TEAD1.
Zeng SG; Xie JH; Zeng QY; Dai SH; Wang Y; Wan XM; Zhou XL
Transl Cancer Res; 2019 Oct; 8(6):2470-2480. PubMed ID: 35116999
[TBL] [Abstract][Full Text] [Related]
2. Exosome-Derived Circ-PVT1 Contributes to Cisplatin Resistance by Regulating Autophagy, Invasion, and Apoptosis Via miR-30a-5p/YAP1 Axis in Gastric Cancer Cells.
Yao W; Guo P; Mu Q; Wang Y
Cancer Biother Radiopharm; 2021 May; 36(4):347-359. PubMed ID: 32799541
[No Abstract] [Full Text] [Related]
3. Circ_PIP5K1A regulates cisplatin resistance and malignant progression in non-small cell lung cancer cells and xenograft murine model via depending on miR-493-5p/ROCK1 axis.
Feng N; Guo Z; Wu X; Tian Y; Li Y; Geng Y; Yu Y
Respir Res; 2021 Sep; 22(1):248. PubMed ID: 34537072
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-106b-5p regulates cisplatin chemosensitivity by targeting polycystic kidney disease-2 in non-small-cell lung cancer.
Yu S; Qin X; Chen T; Zhou L; Xu X; Feng J
Anticancer Drugs; 2017 Sep; 28(8):852-860. PubMed ID: 28723865
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-138 acts as a tumor suppressor in non small cell lung cancer via targeting YAP1.
Xiao L; Zhou H; Li XP; Chen J; Fang C; Mao CX; Cui JJ; Zhang W; Zhou HH; Yin JY; Liu ZQ
Oncotarget; 2016 Jun; 7(26):40038-40046. PubMed ID: 27223073
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-185-5p modulates chemosensitivity of human non-small cell lung cancer to cisplatin via targeting ABCC1.
Pei K; Zhu JJ; Wang CE; Xie QL; Guo JY
Eur Rev Med Pharmacol Sci; 2016 Nov; 20(22):4697-4704. PubMed ID: 27906433
[TBL] [Abstract][Full Text] [Related]
7. miR-186-5p targeting SIX1 inhibits cisplatin resistance in non-small-cell lung cancer cells (NSCLCs).
Liu X; Zhou X; Chen Y; Huang Y; He J; Luo H
Neoplasma; 2020 Jan; 67(1):147-157. PubMed ID: 31686523
[TBL] [Abstract][Full Text] [Related]
8. Circular RNA Gprc5a Promotes HCC Progression by Activating YAP1/TEAD1 Signalling Pathway by Sponging miR-1283.
Lin Y; Huang G; Jin H; Jian Z
Onco Targets Ther; 2020; 13():4509-4521. PubMed ID: 32547082
[TBL] [Abstract][Full Text] [Related]
9. miR-424-5p Regulates Hepatoma Cell Proliferation and Apoptosis.
Piao L; Wang F; Wang Y; Yang Z; Li Q; Cui L; Yu Q
Cancer Biother Radiopharm; 2019 Apr; 34(3):196-202. PubMed ID: 30676784
[TBL] [Abstract][Full Text] [Related]
10. MiR-139-5p Targetedly Regulates YAF2 and Mediates the AKT/P38 MAPK Signaling Pathway to Alleviate the Metastasis of Non-Small Cell Lung Cancer Cells and Their Resistance Against Cisplatin.
Yan Y; Jin X; Sun H; Pang S; Kong X; Bu J; Xu S
Cancer Manag Res; 2021; 13():3639-3650. PubMed ID: 33981163
[TBL] [Abstract][Full Text] [Related]
11. LncRNA SNHG1 contributes to the cisplatin resistance and progression of NSCLC via miR-330-5p/DCLK1 axis.
Ge P; Cao L; Zheng M; Yao Y; Wang W; Chen X
Exp Mol Pathol; 2021 Jun; 120():104633. PubMed ID: 33753110
[TBL] [Abstract][Full Text] [Related]
12. Effect of miR-140-5p on the regulation of proliferation and apoptosis in NSCLC and its underlying mechanism.
Zhou W; Wang X; Yin D; Xue L; Ma Z; Wang Z; Zhang Q; Zhao Z; Wang H; Sun Y; Yang Y
Exp Ther Med; 2019 Aug; 18(2):1350-1356. PubMed ID: 31363375
[TBL] [Abstract][Full Text] [Related]
13. Circ_0076305 regulates cisplatin resistance of non-small cell lung cancer via positively modulating STAT3 by sponging miR-296-5p.
Dong Y; Xu T; Zhong S; Wang B; Zhang H; Wang X; Wang P; Li G; Yang S
Life Sci; 2019 Dec; 239():116984. PubMed ID: 31647948
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA MALAT1 regulates proliferation, apoptosis, migration and invasion via miR-374b-5p/SRSF7 axis in non-small cell lung cancer.
Song J; Su ZZ; Shen QM
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1853-1862. PubMed ID: 32141554
[TBL] [Abstract][Full Text] [Related]
15. MiR-195-5p Inhibits Proliferation and Induces Apoptosis of Non-Small Cell Lung Cancer Cells by Targeting CEP55.
Luo J; Pan J; Jin Y; Li M; Chen M
Onco Targets Ther; 2019; 12():11465-11474. PubMed ID: 31920335
[TBL] [Abstract][Full Text] [Related]
16. The Molecular Mechanism of the TEAD1 Gene and miR-410-5p Affect Embryonic Skeletal Muscle Development: A miRNA-Mediated ceRNA Network Analysis.
Hu W; Wang X; Bi Y; Bao J; Shang M; Zhang L
Cells; 2023 Mar; 12(6):. PubMed ID: 36980284
[TBL] [Abstract][Full Text] [Related]
17. DLX6-AS1 activated by H3K4me1 enhanced secondary cisplatin resistance of lung squamous cell carcinoma through modulating miR-181a-5p/miR-382-5p/CELF1 axis.
Zhao X; Wang J; Zhu R; Zhang J; Zhang Y
Sci Rep; 2021 Oct; 11(1):21014. PubMed ID: 34697393
[TBL] [Abstract][Full Text] [Related]
18. MiR-219a-5p enhances cisplatin sensitivity of human non-small cell lung cancer by targeting FGF9.
Rao C; Miao X; Zhao G; Zhang C; Shen H; Dong C; Yang M
Biomed Pharmacother; 2019 Jun; 114():108662. PubMed ID: 30999114
[TBL] [Abstract][Full Text] [Related]
19. Loss of MiR-424-3p, not miR-424-5p, confers chemoresistance through targeting YAP1 in non-small cell lung cancer.
Zhang M; Zeng J; Zhao Z; Liu Z
Mol Carcinog; 2017 Mar; 56(3):821-832. PubMed ID: 27500472
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-7-5p induces cell growth inhibition, cell cycle arrest and apoptosis by targeting PAK2 in non-small cell lung cancer.
Li Q; Wu X; Guo L; Shi J; Li J
FEBS Open Bio; 2019 Nov; 9(11):1983-1993. PubMed ID: 31587474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]